Loading search results
TXT4FLUJAB
A Feasibility Study for a Cluster Randomised Trial of Text Messaging Reminders for Influenza Vaccine in Patients Under 65 in Clinical Risk Groups in English Primary Care.
Sponsor study identifier
interventional
156
1 country
1
Study Start
September 2013
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2015
Actual (reported)Study Completion
December 2015
Actual (reported)Influenza morbidity and mortality cause a substantial financial burden to the NHS and to the UK as a whole. Influenza vaccine is safe and effective but is required annually because the circulating strain of virus changes each year. In the UK in 2012, the Chief Medical Officer (CMO) recommended that at least 75% of elderly people (aged 65+) and 75% people under 65 with certain chronic conditions (e.g. chronic heart disease, diabetes, asthma, etc) should be vaccinated. While primary care practices are achieving these targets for elderly patients, those set for younger patients with chronic conditions are not being met, with a third of patients being missed in the 2011/12 flu season and with no substantial improvements in uptake in the past decade. Therefore strategies to increase flu vaccine uptake in these patients are required. Previous trials have shown that patient reminders can increase vaccine uptake and in particular, text messaging has shown to work in some populations in the United States as a cheap, simple and effective reminder. However, whether the same is true in UK general practice is unclear. The use of text messaging in the NHS for appointment reminders is also increasing as it is cheap, quick and effective. Text messaging is already used in roughly 30% of practices to remind patients about their flu vaccine but there has been no trial addressing its effectiveness. Therefore, we propose a trial of a text messaging flu vaccine reminder in patients aged under 65 who have a chronic condition. We hypothesise that practices that send a text message will have increased flu vaccine uptake.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2015
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 13, 2013
Actual (reported)July 4, 2013
Actual (reported)September 2013
Date type not reportedThis date has not been verified as actual or estimated.
December 2015
Actual (reported)December 2015
Actual (reported)Proportion of patients at risk who received flu vaccine
up to 9 months
Proportion of practices reporting 'yes' to difficulties
up to 3 months
Recruitment rate
3 months after initial contact
Practice delivery of text message
One month after study start (October 1st 2013)
Were outcome data available
up to 9 months
Practices in the standard care arm will proceed with their seasonal influenza campaign as planned.
Practices in the text messaging intervention arm will be asked to send a text message to patients under 65 at risk of influenza.
Practices in the text messaging intervention arm will be asked to send a text message to patients under 65 at risk of influenza.
Practices in the standard care arm will be asked to proceed with their seasonal influenza campaign as planned.
London School of Hygiene and Tropical Medicine
London, Select County, WC1E 7HT, United Kingdom
156 participants (actual enrollment reported by the registry).
First Submitted
June 13, 2013
First Posted
July 4, 2013
Study Start
September 2013
Date type not reportedThis date has not been verified as actual or estimated.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
December 2015
Actual (reported)Study Completion
December 2015
Actual (reported)Last Updated
October 24, 2016
Record last verified: 2015-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: